Lipoprotein lipase D9N, N291S and S447X polymorphisms: Their influence on premature coronary heart disease and plasma lipids

Atherosclerosis

Volumn 157, Issue 1, 2001, Pages 123-129

  Van Bockxmeer, Frank M ^a,b   Liu, Qinghua ^b   Mamotte, Cyril ^b   Burke, Valerie ^a   Taylor, Roger ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Coronary disease; Genetic polymorphism; Lipids; Lipoprotein lipase

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; RISK FACTOR; SEX; SMOKING;

ADULT; ALLELES; CORONARY DISEASE; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MALE; POLYMORPHISM, GENETIC;

EID: 0034966105     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00717-6     Document Type: Article

References (25)

1. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase
2. Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis
3. Ile225 Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event
4. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis
5. The ASN9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease
6. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen City Heart Study
7. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: The Framingham Offspring Study
8. Apolipoprotein ε4 homozygosity - A determinant of restenosis after coronary angioplasty
9. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Functional implications and prevalence in normal and hyperlipidemic subjects
10. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis
11. Ser 447 stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males
12. Triglyceride. The forgotten risk factor
13. Interaction of the lipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: A study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults
14. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease
15. Lipoprotein lipase gene polymorphisms: Associations with myocardial infarction and lipoprotein levels, the ECTIM study
16. The low down on lipoprotein lipase
17. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations. Studies in the fasting and postprandial states: The European Atherosclerosis Research Studies
18. 9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis
19. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study
20. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population
21. 447-Stop substitution in the lipoprotein lipase gene
22. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
23. Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
24. Receptor-mediated mechanisms of lipoprotein remnant catabolism
25. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E